$ITOR
Intorio, Corp.

2023 Q2 Form 10-Q Financial Statement

#000168316823004517 Filed on June 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $1.350K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.23K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $670.00
YoY Change
% of Gross Profit
Operating Expenses $11.23K $10.42K
YoY Change 7.76%
Operating Profit -$9.877K -$10.42K
YoY Change -5.2%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.880K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.877K -$10.42K
YoY Change -5.2% 57.89%
Net Earnings / Revenue -731.63%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.235M shares 3.235M shares
Diluted Shares Outstanding 3.235M shares 3.235M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.660K
YoY Change
Cash & Equivalents $2.660K $7.596K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.660K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.998K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.660K
Total Long-Term Assets $2.998K
Total Assets $5.658K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.00K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $17.54K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $40.54K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $40.54K
Total Long-Term Liabilities $0.00
Total Liabilities $40.54K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$59.78K
YoY Change
Common Stock $324.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$34.88K -$9.978K
YoY Change
Total Liabilities & Shareholders Equity $5.658K
YoY Change

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$9.877K -$10.42K
YoY Change -5.2% 57.89%
Depreciation, Depletion And Amortization $670.00
YoY Change
Cash From Operating Activities -$7.710K -$8.252K
YoY Change -6.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $8.560K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -$7.710K -$8.252K
Cash From Investing Activities
Cash From Financing Activities $8.560K $0.00
Net Change In Cash $850.00 -$8.252K
YoY Change -110.3%
FREE CASH FLOW
Cash From Operating Activities -$7.710K -$8.252K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001852536
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-255055
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Intorio, Corp.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578603
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
24 Alexander Kazbegi Ave
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Tblisi
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0177
CY2023Q2 dei Entity Address Country
EntityAddressCountry
GE
CY2023Q2 dei City Area Code
CityAreaCode
(702)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
605-4636
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3235000 shares
CY2023Q2 us-gaap Cash
Cash
2660 usd
CY2023Q1 us-gaap Cash
Cash
1810 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2660 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1810 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6002 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2998 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3665 usd
CY2023Q2 us-gaap Assets
Assets
5658 usd
CY2023Q1 us-gaap Assets
Assets
5475 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21500 usd
CY2023Q2 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
17540 usd
CY2023Q1 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
8981 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
40540 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30481 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
324 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
324 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59783 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-34883 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25006 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5658 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5475 usd
CY2023Q2 us-gaap Revenues
Revenues
1350 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11227 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10419 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11227 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
10419 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9877 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10419 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-9877 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-10419 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9877 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10419 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10419 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9978 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25006 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9877 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-34883 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9877 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10419 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
667 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
667 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1500 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1500 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7710 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8252 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8560 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8560 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
850 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8252 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1810 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15848 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2660 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7596 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59783 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zztfwndo73Bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_865_zVoauJbfpF83"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations during the reporting period, the Company made no material assumptions or estimates other than the assumption that the Company is a going concern and estimate with reference to amortization of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2023Q2 us-gaap Cash
Cash
2660 usd
CY2023Q1 us-gaap Cash
Cash
1810 usd
CY2023Q2 us-gaap Revenues
Revenues
1350 usd
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
667 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21500 usd

Files In Submission

Name View Source Status
0001683168-23-004517-index-headers.html Edgar Link pending
0001683168-23-004517-index.html Edgar Link pending
0001683168-23-004517.txt Edgar Link pending
0001683168-23-004517-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
intorio_ex3101.htm Edgar Link pending
intorio_ex3102.htm Edgar Link pending
intorio_ex3201.htm Edgar Link pending
intorio_i10q-053123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230531.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
none-20230531_def.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20230531_lab.xml Edgar Link unprocessable
none-20230531_pre.xml Edgar Link unprocessable
intorio_i10q-053123_htm.xml Edgar Link completed
none-20230531_cal.xml Edgar Link unprocessable